International Patient Summary Implementation Guide
1.0.0 - CI Build

International Patient Summary Implementation Guide, published by Health Level Seven International - Patient Care Work Group. This is not an authorized publication; it is the continuous build for version 1.0.0). This version is based on the current content of https://github.com/HL7/fhir-ips/ and changes regularly. See the Directory of published versions

Table of Contents

..0 Table of Contents
...1 International Patient Summary Implementation Guide
...2 General Principles
...3 Design Conventions and Principles
...4 Known Issues and Future Development
...5 IPS Structure
...6 Profiles defined as part of the IPS Guide
...7 Datatypes defined for this Guide
...8 Extensions
...9 Terminology artifacts defined as part of the IPS Implementation Guide
...10 Examples
...11 Downloads
...12 Copyrights
...13 Artifacts Summary
....13.1 Patient (IPS)
....13.2 Observation Results: radiology (IPS)
....13.3 Observation (SH: alcohol use)
....13.4 Organization (IPS)
....13.5 PractitionerRole (IPS)
....13.6 Observation Results (IPS)
....13.7 Imaging Study (IPS)
....13.8 Device (performer, observer)
....13.9 Composition (IPS)
....13.10 Practitioner (IPS)
....13.11 Observation (SH: tobacco use)
....13.12 Condition (IPS)
....13.13 Observation (Pregnancy: outcome)
....13.14 Device (IPS)
....13.15 Procedure (IPS)
....13.16 Media observation (Results: laboratory, media)
....13.17 Specimen (IPS)
....13.18 Medication Statement (IPS)
....13.19 Observation (Pregnancy: EDD)
....13.20 Medication (IPS)
....13.21 Observation Results: laboratory (IPS)
....13.22 Observation (Pregnancy: status)
....13.23 DiagnosticReport (IPS)
....13.24 Device Use Statement (IPS)
....13.25 Observation Results: pathology (IPS)
....13.26 Immunization (IPS)
....13.27 Allergy Intolerance (IPS)
....13.28 Range (IPS)
....13.29 Codeable Concept (IPS)
....13.30 Quantity (IPS)
....13.31 Ratio (IPS)
....13.32 Coding with translations
....13.33 SimpleQuantity (IPS)
....13.34 Condition abatement date
....13.35 Results Organism (GPS) - IPS
....13.36 Absent or Unknown Medication - IPS
....13.37 Pregnancies Summary - IPS
....13.38 Results Radiology Textual Observations (GPS-DICOM-LOINC) - IPS
....13.39 Medicine Active Substances - IPS
....13.40 Problem Severity - IPS
....13.41 Problem Type - IPS
....13.42 Pregnancy Status - IPS
....13.43 Results Coded Values Laboratory (GPS) - IPS
....13.44 Results Radiology Observation - IPS
....13.45 Results Specimen Type (GPS) - IPS
....13.46 Medical Devices - IPS
....13.47 Vaccines - IPS
....13.48 Results Specimen Collection Method (GPS) - IPS
....13.49 WHO ATC - IPS
....13.50 SNOMED International Global Patient Set (GPS)
....13.51 Allergy intolerance substance condition - IPS
....13.52 Target Site - IPS
....13.53 Absent or Unknown Devices - IPS
....13.54 Current Smoking Status - IPS
....13.55 Medications (example) - IPS
....13.56 Vaccines (GPS) - IPS
....13.57 Allergy Reaction (GPS) - IPS
....13.58 Pregnancy Expected Delivery Date Method - IPS
....13.59 Medicine Doseform - IPS
....13.60 Absent or Unknown Procedures - IPS
....13.61 Results Radiology Measurement Observation (GPS-DICOM) - IPS
....13.62 Absent or Unknown Problems - IPS
....13.63 Absent or Unknown Allergies - IPS
....13.64 Vaccine Target Diseases (GPS) - IPS
....13.65 Results Laboratory Observation - IPS
....13.66 Absent or Unknown Immunization - IPS
....13.67 Medications (SNOMED CT) - IPS
....13.68 Procedures - IPS
....13.69 Healthcare Professional Roles - IPS
....13.70 Allergy intolerance substance condition (GPS) - IPS
....13.71 Vaccine Target Diseases - IPS
....13.72 Results Laboratory ABO+RH Group (GPS) - IPS
....13.73 Results Pathology Observation - IPS
....13.74 Personal Relationship - IPS
....13.75 Results Coded Values Pathology (GPS) - IPS
....13.76 Medicine Route of Administration - IPS
....13.77 CORE Problem List Finding/Situation/Event (GPS) - IPS
....13.78 Results Laboratory Presence/Absence (GPS) - IPS
....13.79 Absent and Unknown Data - IPS
....13.80 Absence of Information Mappings - IPS to SNOMED CT
....13.81 Severity Value Set Mappings - LOINC to FHIR
....13.82 Severity Value Set Mappings - SNOMED CT to FHIR
....13.83 IPS Bundle example
....13.84 Medication : Simvastatin 40 MG Disintegrating Oral Tablet
....13.85 MedicationStatement: on-going Simvastatin treatment
....13.86 Immunization: Vaccin anti diphtérie-coqueluche-tétanos-poliomyélite (Luxembourg)
....13.87 AllergyIntolerance: No known allergies
....13.88 AllergyIntolerance: resolved allergy
....13.89 Condition: Acute myocardial infarction of anterior wall
....13.90 Procedure: Surgical procedure
....13.91 Practitioner example
....13.92 PractitionerRole: simple example
....13.93 Patient: male patient
....13.94 Patient: minimal example
....13.95 Patient: female patient
....13.96 DeviceUseStatement: No known devices in use
....13.97 Device: No known devices in use
....13.98 Device: device observer example
....13.99 Observation: imaging CT Abdomen W contrast IV
....13.100 Observation: imaging CT Abdomen W contrast IV, sub-observations
....13.101 ImagingStudy: referred DICOM study
....13.102 Organization: example
....13.103 Organization: simple example
....13.104 Organization: lab example
....13.105 Observation: pregnancy edd example
....13.106 Observation: pregnancy status example
....13.107 Observation: pregnancy outcome example
....13.108 Observation: SH tobaccouse example
....13.109 Observation: SH alcoholuse example
....13.110 Specimen: example
....13.111 Observation: serum creatinine example
....13.112 Observation: hemoglobin example
....13.113 Observation: estrogen receptor in tissue example
....13.114 DiagnosticReport: hemoglobin example
....13.115 Media: example